- Home
- SPRC vs APRE Comparison
SPRC vs APRE Comparison
Compare SPRC & APRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRC
- APRE
- Stock Information
- Founded
- SPRC 2004
- APRE 2006
- Country
- SPRC Israel
- APRE United States
- Employees
- SPRC N/A
- APRE N/A
- Industry
- SPRC Biotechnology: Pharmaceutical Preparations
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SPRC Health Care
- APRE Health Care
- Exchange
- SPRC Nasdaq
- APRE Nasdaq
- Market Cap
- SPRC 7.3M
- APRE 8.3M
- IPO Year
- SPRC N/A
- APRE 2019
- Fundamental
- Price
- SPRC $4.27
- APRE $1.56
- Analyst Decision
- SPRC
- APRE Strong Buy
- Analyst Count
- SPRC 0
- APRE 1
- Target Price
- SPRC N/A
- APRE $20.00
- AVG Volume (30 Days)
- SPRC 7.0M
- APRE 105.1K
- Earning Date
- SPRC 01-01-0001
- APRE 11-06-2025
- Dividend Yield
- SPRC N/A
- APRE N/A
- EPS Growth
- SPRC N/A
- APRE N/A
- EPS
- SPRC N/A
- APRE N/A
- Revenue
- SPRC $1,306,000.00
- APRE $841,012.00
- Revenue This Year
- SPRC N/A
- APRE N/A
- Revenue Next Year
- SPRC N/A
- APRE N/A
- P/E Ratio
- SPRC N/A
- APRE N/A
- Revenue Growth
- SPRC N/A
- APRE N/A
- 52 Week Low
- SPRC $1.75
- APRE $1.37
- 52 Week High
- SPRC $37.59
- APRE $5.00
- Technical
- Relative Strength Index (RSI)
- SPRC 50.89
- APRE 55.50
- Support Level
- SPRC $3.75
- APRE $1.40
- Resistance Level
- SPRC $4.48
- APRE $1.69
- Average True Range (ATR)
- SPRC 0.50
- APRE 0.09
- MACD
- SPRC -0.06
- APRE 0.02
- Stochastic Oscillator
- SPRC 38.85
- APRE 62.71
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.